INmune Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
INMB Key Statistics
Stock Snapshot
With a market cap of 33.63M, INmune Bio(INMB) trades at $1.26. The stock has a price-to-earnings ratio of -0.74.
On 2026-06-06, INmune Bio(INMB) stock traded between a low of $1.24 and a high of $1.37. Shares are currently priced at $1.26, which is +1.6% above the low and -8.0% below the high.
INmune Bio(INMB) shares are trading with a volume of 328.11K, against a daily average of 332.99K.
During the past year, INmune Bio(INMB) stock moved between $1.09 at its lowest and $11.64 at its peak.
During the past year, INmune Bio(INMB) stock moved between $1.09 at its lowest and $11.64 at its peak.
INMB News
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
INmune Bio (INMB) announced positive results from exploratory MRI imaging analyses of its MINDFuL Phase 2 trial of XPro in patients with early Alzheimer’s disea...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.